Ximatof (Cefotaxime) is indicated for the treatment of the following infections due to susceptible microorganisms:
– Respiratory tract infections
– Genitourinary infections
– Gynecologic infections
– Bacteremia/Septicemia
– Skin and skin structure infections
– Intra-abdominal infections
– Lyme-borreliosis (especially stages II and III)
– Bone and/or joint infections
– Central nervous system infections
– Endocarditis